China Biotechs See Manufacturing Disruption As Cases Hit Suzhou
Shanghai Lockdown GDP Impact
As Shanghai's COVID-19 outbreak and lockdowns continue, neighboring biotech cluster Suzhou is now imposing restrictions, with firms there expecting large disruptions to manufacturing and clinical study halts amid few signs of easing in China's "COVID Zero" policies.
